
Boltz raises $110M led by Bessemer to sell AI drug design models
The MIT spinout behind the open-source Boltz-2 model says paid usage grew 50-fold since June, with Pfizer, GSK, Takeda and BMS as partners.
Every ClaudeGPT Si story about Boltz, newest first: news, analysis, reviews and guides.
1 story · Updated

The MIT spinout behind the open-source Boltz-2 model says paid usage grew 50-fold since June, with Pfizer, GSK, Takeda and BMS as partners.